Upcoming Medical Conferences in Austria

EUSTM-2019 - 6th Annual European Congress on Clinical and Translational Medicine is organized by European Society for Translational Medicine (EUSTM) and will be held from Oct 18 - 20, 2019 at Vienna Marriott Hotel, Wien, Austria. Target Audience: The conference will unite scientists, clinicians, public health professional, world leaders and experts from research institutions, pharma, vaccines and biotech industry, regulatory agencies, policy makers, and governments. Description: Unique exclusively to this congress will be our consensus building discussions on standardization of Preventive Medicine definition and elaboration of significance of Preventive Medicine tools and approaches including vaccines, clinical epidemiology, health promotion and others. EUSTM provides the key to future success in translational medicine by offering an interdisciplinary forum to address current challenges and highlight novel solutions. The conference represents a unique opportunity for global networking with key opinion leaders and service providers. Participants will also include practicing physicians with clinical experience in various therapeutic areas and members of patient organizations. Pharma and biotech industries, medtech and medical instruments companies, consultancy firms, clinical research organizations and data management companies will showcase and exhibit their products and services. Congress Tracks: • Cellular Biology • Molecular Medicine • Biomarkers • Clinical Case Reports • Clinical Trials • Clinical Studies • Preventive Medicine • Vaccines Professional Diploma Course in Translational Medicine (PDipTM) Post-Congress Day: 20th October, 2019 (Extra registration Required) Course Accreditation: 7 CPD Points by the Faculty of Pharmaceutical Medicine, Royal Colleges of Physicians, UK Additional details will be posted as soon as they are available.

International Cytokine and Interferon Society (ICIS) 7th Annual Meeting is organized by International Cytokine & Interferon Society (ICIS) and would be held during Oct 20 - 23, 2019 at Vienna, Wien, Austria. Additional details will be posted as soon as they are available.

7th Annual Meeting of the International Cytokine & Interferon Society is organized by MCI Suisse SA and will be held from Oct 20 - 23, 2019 at Hofburg Congress Center, Vienna, Wien, Austria. Description: Cytokine targeting has become one of the greatest revolutions in modern medicine. A large number of severe and sometimes even lethal inflammatory and autoimmune diseases have become manageable due to selective inhibition of cytokines and cytokine signaling. The development of compounds that selectively inhibit cytokines or interferons has permitted an so far unprecedented molecular characterization of human disease. Cytokines also contribute to cancer development and alterations in tissue homeostasis. Cytokines 2019 will address these developments and provide a comprehensive picture of the current knowledge of cytokine pathways in human disease and the strategies to inhibit, modulate or foster cytokine responses. Topics: Following specific topics will be addressed: • Mechanisms and treatment of inflammation: The IL-23/IL-17 pathway • Biology and targeting of type 2-mediated immune responses • Pro-resolving and immune-regulatory cytokines: Control of inflammation and autoimmunity • Local and systemic effects of IL-1 family cytokines in disease • The biology of IL-6 and the role of IL-6 inhibition in disease • Type I interferons: biology and their role in disease • Immune metabolism-regulating cytokine production and immune cell polarization • Therapeutic targeting of the cytokine signaling pathways • Cytokine-related diseases after checkpoint inhibition • Cytokine-mediated resident tissue destruction and fibrotic responses • Control of inflammation by inflammatory cytokines • Cytokine effects on the brain: molecular control of pain, sickness behavior and depression • Targeting neutrophils and macrophagesin immune-mediated disease • Induction of immune tolerance –fact or fiction? Additional details will be posted as soon as information is available.

9th International Seminar of the European Palliative Care Research Centre (PRC) is organized by Oslo University Hospital and will be held from Oct 23 - 25, 2019 at Krems, Lower Austria, Austria. Topics: • Integration of oncology and palliative care • End of life care • New drugs – still a need for palliative care? • Patient-reported outcome measures • Cancer pain • Patient-centred care • Cancer cachexia Highlights from the program: • Integration of oncology and palliative care • End of life care • New drugs - still a need for palliative care? • Patient reported outcome measures • Cancer pain • Cancer cachexia • Patient - centred care Additional details will be posted as soon as they are available.

Diagnostic Breast Pathology Course is organized by Vincent Academy of Pathology (VAP) and will be held from Oct 23 - 25, 2019 at Lentos Art Museum Linz, Linz, Upper Austria, Austria. Participants: This course is designed for practicing pathologists as well as pathologists in training. Attendance is limited to 80 participants. Course Objectives: During the course, the participants will be able to review at least 60 cases dealing with a variety of benign and malignant breast neoplasms and tumor-like lesions. Several common diagnostic problems including papillary neoplasms, intraductal proliferative lesions, variants of ductal and lobular intraepithelial neoplasias, and infiltrating carcinomas are included. On each day, at least 20 cases will be reviewed by the participants using conventional (on-site) microscopy. All cases will be extensively discussed by the faculty members using an interactive approach (live microscopic presentation of the cases). Particular attention will be paid to the diagnostic criteria with systematic analysis of differential diagnoses. Value and limitations of immunohistochemistry and molecular-genetic tools will be demonstrated and critically discussed. A comprehensive review and update of histopathology with discussion of clinical significance of benign, intraepithelial, and malignant tumors of the breast will be provided. In addition to the case discussion, several lectures by experts in pathology, medical oncology, and surgery will be provided. After the course, the participants will have access for four weeks to review all digitized cases via internet. Prior to the course, however, there is no internet access to the selected cases. Additional details will be posted as soon as information is available.

14th EUROPA DONNA Pan-European conference is organized by Europa Donna - The European Breast Cancer Coalition and will be held from Oct 26 - 27, 2019 at Imperial Riding School Renaissance Vienna Hotel, Vienna, Wien, Austria.  Conference Description: This conference and will give advocates an overview of advocacy progress over the years as well as provide updated information to help them improve breast services in their countries. Scientific experts will provide lectures on research, breast imaging, breast surgery, and what women with high genetic risk should know. Implementation of the ECIBC project will be covered as well as topics of interest to advocates such as return to work after breast cancer and dealing with long term effects of breast cancer treatment. Advocates will participate in workshops giving them practical guidance on managing long term survivorship, strategies for return to work, and how to advocate for implementation of the ECIBC nationally. Special networking groups for young women with breast cancer, women with metastatic breast cancer and women with high genetic risk Additional details will be posted as soon as they are available.

Cancer Drug Development Forum (CCDF) 11th Alpine Conference on 'Current and Future Challenges of Innovative Oncology Drugs Development' is organized by Cancer Drug Development Forum (CDDF) and will be held from Oct 28 - 30, 2019 at Innsbruck, Tyrol, Austria. Additional details will be posted as soon as they are available.

ISIN 2019 Vienna - 7th Congress of the International Society of Intraoperative Neurophysiology Congress and Educational Course is organized by Vienna Medical Academy (VMA) / Wienner Medizinische Akademie (WMA) and will be held from Oct 28 - Nov 02, 2019 at InterContinental Vienna, Vienna, Wien, Austria. Target Audience: The target audience for this medical event is surgeons, neurophysiologists, neurologists, anesthesiologists and technicians, as well as for students in medicine and neuroscientists is a unique advantage to learn from a distinguished faculty of experienced neurophysiologists and surgeons about basics and application in high risk surgery. Conference Description: Techniques in surgery are under fast development, not only influencing the indications of surgery but also challenging the safety of the surgical interventions. Intraoperative neurophysiology offers an additional safety net for the neurological outcome in neurosurgery, orthopedic surgery and many other fields of surgery. Thus, neurophysiological monitoring has become an essential tool of intraoperative neuroprotection. The Scientific Congress will be a platform for communication for all related medical and scientific fields. It serves a roundtable for interprofessional exchange between scientists, clinicians, technicians and the medical industry. We invite participants from all over the world, to contribute their experiences and to communicate their requests within an interdisciplinary scientific environment. Topics: • Brain tumor surgery • Cerebral vascular surgery • Brainstem & skull base surgeries • Spine & spinal cord surgeries • Peripheral nerve & plexus surgeries • Brain mapping & epilepsy surgeries • Neuromonitoring methodologies & techniques • Free topics Additional details will be posted as soon as they are available.

Patient Centered Meeting (PCM) on Diabetes, Dyslipidemia and Hypertension is organized by Paragon Group and will be held from Oct 31 - Nov 03, 2019 at Imperial Riding School Renaissance Vienna Hotel, Vienna, Wien, Austria. The target audience for this medical event is General Internists, Diabetologists, lipidologists, Nephrologists, Cardiologists, Neurologists, Vascular Surgeons, Clinical researchers, Specialists managing patients with increased CVD risk - eg HIV, rheumatoid arthritis etc., Primary care physicians (GP's), Pharmacists. Course Objectives: After participating in this educational event, and within the framework of diabetes, hypertension and lipid management, participants should be able to: • Critically and systematically review current guidelines (changes) • Implement standard therapeutic protocols • Objectively recognize and address needs of individual patients • Identify those patients in whom alternative, innovative treatment approaches are deemed necessary • Understand new developments in diagnostic tools • Understand and implement strategies to improve medication compliance, persistence and adherence • Discuss challenging patients to colleagues and /or faculty • Access available on-line resources provided by the PCM course • Cutting edge know how and updates that can be useful in the daily practice • Enhanced skills which can be applied directly in everyday practice We are launching a new type of clinical conference - a Patient Centered Meeting (PCM), a patient centered approach that would take the target audience from guidelines toward personalized medicine. The first will focus on diabetes, hypertension and dyslipidemia. Our aim is to empower clinicians managing patients with these major risk factors. The attendee's clinical tool box will be enriched: In the field of diabetes: • The "growing" epidemic of obesity and its impact on diabetes, both type 1 and esp type 2 diabetes • Pathophysiology of type 2 diabetes • Diagnostic approaches to diabetes, and the importance of diagnosing pre diabetes • guidelines for the management of diabetes • New therapeutic approaches In the field of dyslipidemia: • Historic perspective of Cholesterol as a treatable CVD risk factor; from diet to statins • Lipid Metabolism; the basics; relevant for clinical lipid management • Primary dyslipdemia; focus on FH: how to recognise, diagnose and treat. • A primary care roadmap for lIpid guidelines and lipid management • New therapeutic strategies; a curated digest for clinicians In the field of hypertension: • Practical and systematic workup of a newly diagnosed hypertension • Stepwise and structured treatment algorithm and goals • Appropriate screening and diagnostic approach to identify secondary hypertension – renal, neuroendocrine, sleep apnea and more • Advanced treatment: Resistant hypertension, paroxysmal and fluctuating hypertension, multiple drugs and side effects Discuss hot topics in hypertension: • When to refer and how to read 24 hours blood pressure monitoring • How to manage orthostatic hypotension and supine hypertension • Extreme sport activity and hypertension • Cardiovascular consideration of medical cannabis • Hypertension and pregnancy • Stress, job strain, anxiety and blood pressure • Novel invasive therapeutic strategies Time: 8:00 am - 5:00 pm

11th European Multidisciplinary Congress on Urological Cancers (EMUC) is organized by European Society for Medical Oncology (ESMO), European Society for Radiotherapy and Oncology (ESTRO), European Association of Urology (EAU) and will be held from Nov 14 - 17, 2019 at Austria Center Vienna, Vienna, Wien, Austria. 3 Reasons Not to Miss EMUC19: Collaborative Approach International experts from various disciplines examine and identify areas of improvement, collaboration and innovation to provide a more optimal management plan for patients with urological malignancies. Specialised Training & Workshops Skills training for urologists, radiologists, pathologists and related healthcare professionals are part of the EMUC Scientific Programme. Dedicated mentors, tutors and leading opinion leaders offer their expertise and practical insights. Innovative research Outcomes of the latest research studies by oncologists, urologists, radiation oncologists, pathologists, epidemiologists and other medical scientists are presented in the Oral Poster Sessions. Join or support your colleagues in the forefront of medical discoveries! Description: EMUC19 is a frontline congress that will identify optimal therapies and address gaps in clinical practices in onco-urology. This congress is designed to encourage relevant discussions on innovative treatment, the limits of standard therapies, and the impact of new research outcomes. Its reputation as prime European platform for professional and scientific exchanges in GU oncology has been well-established throughout the years. Skills training for urologists, radiologists, pathologists and related healthcare professionals are always part of the EMUC Scientific Programme.  This Congress aims to identify which contemporary imaging methods are beneficial to which situation; and what kind of standardisation of reporting of different urological cancers are to be expected. Additional details will be posted as soon as they are available.